In corporate governance news, Bryan Supran, a Non-Executive Director representing Pfizer (NYSE:PFE), has stepped down from Haleon’s board following Pfizer’s reduction of its stake in the ...

Realty Income has a solid strategy. It largely caters to companies in non-discretionary, service-oriented, non-retail, and ...

GSK's main partner in the consumer health joint venture that became Haleon – Pfizer – holds the remaining 32% in the new company and has said that it will sell its stake now that the ...

Haleon HLN-2.04%decrease ... The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said Thursday that it made a pretax profit of 1.91 billion pounds ($2.42 billion ...

Pfizer to sell $3 billion stake in Sensodyne maker Haleon Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare ...

Pfizer sold 700 million ordinary shares of its investment in Haleon for approximately $3.0 billion, which brings down its stake in Haleon from approximately 15% to approximately 7%. Currently ...

LONDON - Haleon PLC (LSE/NYSE: HLN), a global consumer health company, announced a change to its Board of Directors today. Following the decline of Pfizer Inc. (NYSE:PFE)’s shareholding in ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...

Pfizer has also increased its dividend for 16 ... from the company's sale of its stake in British pharmaceutical company Haleon. Management also seems confident on its cash-flow generating ...